Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chai

Showing results (311-320 of 339) with videos related to

Pageof 34
Sort By:
Contemporary Clinical Trials|July 29, 2009
Design of the Value of Urodynamic Evaluation (ValUE) trial: A non-inferiority randomized trial of preoperative urodynamic investigationsCharles W Nager, Linda Brubaker, Firouz Daneshgari, et al.
Oncotarget|October 6, 2017
Melphalan modifies the bone microenvironment by enhancing osteoclast formationRyan C Chai, Michelle M McDonald, Rachael L Terry, et al.
European Journal of Medicinal Chemistry|March 10, 2023
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitorsMladen Koravovic, Anand Mayasundari, Gordana Tasic, et al.
Blood Neoplasia|May 11, 2026
Microenvironmentally derived fatty acid-binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myelomaHaylee Duval, Katherine Knox, Heather Fairfield, et al.
Cancer Cell|August 13, 2015
The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and MetastasisLisa M Ooms, Lauren C Binge, Elizabeth M Davies, et al.
Bioorganic & Medicinal Chemistry|November 25, 2017
Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitorsWilliam R Shadrick, Peter J Slavish, Sergio C Chai, et al.
Cell Death & Disease|November 9, 2013
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)R Y-J Huang, M K Wong, T Z Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2026
A human cardiomyocyte screen identifies optimized lipid nanoparticles for in vivo cardiac gene editingYehui Sun, Yu-Chung Pien, Yufen Xiao, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 24, 2010
Fifth joint meeting of the American Urological Association and the Japanese Urological Association International Affiliate Society Meeting at the 105th Annual Meeting of the American Urological AssociationRobert P Myers, Narihito Seki, Momokazu Gotoh, et al.
The Journal of Urology|January 18, 2011
Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learnedClaire C Yang, David A Burks, Kathleen J Propert, et al.
Pageof 34

Showing results (311-320 of 339) with videos related to

Sort By:
Pageof 34
Contemporary Clinical Trials|July 29, 2009
Design of the Value of Urodynamic Evaluation (ValUE) trial: A non-inferiority randomized trial of preoperative urodynamic investigationsCharles W Nager, Linda Brubaker, Firouz Daneshgari, et al.
Oncotarget|October 6, 2017
Melphalan modifies the bone microenvironment by enhancing osteoclast formationRyan C Chai, Michelle M McDonald, Rachael L Terry, et al.
European Journal of Medicinal Chemistry|March 10, 2023
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitorsMladen Koravovic, Anand Mayasundari, Gordana Tasic, et al.
Blood Neoplasia|May 11, 2026
Microenvironmentally derived fatty acid-binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myelomaHaylee Duval, Katherine Knox, Heather Fairfield, et al.
Cancer Cell|August 13, 2015
The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and MetastasisLisa M Ooms, Lauren C Binge, Elizabeth M Davies, et al.
Bioorganic & Medicinal Chemistry|November 25, 2017
Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitorsWilliam R Shadrick, Peter J Slavish, Sergio C Chai, et al.
Cell Death & Disease|November 9, 2013
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)R Y-J Huang, M K Wong, T Z Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2026
A human cardiomyocyte screen identifies optimized lipid nanoparticles for in vivo cardiac gene editingYehui Sun, Yu-Chung Pien, Yufen Xiao, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 24, 2010
Fifth joint meeting of the American Urological Association and the Japanese Urological Association International Affiliate Society Meeting at the 105th Annual Meeting of the American Urological AssociationRobert P Myers, Narihito Seki, Momokazu Gotoh, et al.
The Journal of Urology|January 18, 2011
Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learnedClaire C Yang, David A Burks, Kathleen J Propert, et al.
Pageof 34